Half-Dose Anticoagulation for Venous Thromboembolism and Phlegmasia Cerulea Dolens in a Patient With Recurrent Subdural Hematoma

Anticoagulation for venous thromboembolism (VTE) in patients with recurrent subdural hematoma (SDH) is challenging. It becomes even more challenging when the patient develops phlegmasia cerulea dolens (PCD). We present a 66-year-old female with a recent history of recurrent SDH who received half-dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Junfei, Chan, Kelley, Adhikari, Nirajan, Khan, Amber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523340/
https://www.ncbi.nlm.nih.gov/pubmed/34692280
http://dx.doi.org/10.7759/cureus.18048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523340/
https://www.ncbi.nlm.nih.gov/pubmed/34692280
http://dx.doi.org/10.7759/cureus.18048

Ejemplares similares